EMulate - Cellsana Therapeutics

Cellsana has large market opportunities in a wide range of cancer indications.

Testing in humans and animals for safety and effectiveness in treating GBM and DMG has produced encouraging results.

Further, test results suggest our technology’s safety and effectiveness for treating solid cancer tumors such as mycosis fungoides, plasma cell tumors, fibrosarcomas, neurofibrosarcomas, schwanomas, malignant melanomas, hermangiopericytomas, hepatic adenocarcinomas, mast cell tumors, adenocarcinomas (mammary), osteosarcomas, chondrosarcomas, apocrine gland adenocarcinamoas, undifferentiated carinomas, and transitional cell carcinomas.